Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 42 TWD 0.36%
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Intrinsic Value

The intrinsic value of one Maxigen Biotech Inc stock under the Base Case scenario is 28.59 TWD. Compared to the current market price of 42 TWD, Maxigen Biotech Inc is Overvalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
28.59 TWD
Overvaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Maxigen Biotech Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Maxigen Biotech Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Maxigen Biotech Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Maxigen Biotech Inc

Provide an overview of the primary business activities
of Maxigen Biotech Inc.

What unique competitive advantages
does Maxigen Biotech Inc hold over its rivals?

What risks and challenges
does Maxigen Biotech Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Maxigen Biotech Inc.

Provide P/S
for Maxigen Biotech Inc.

Provide P/E
for Maxigen Biotech Inc.

Provide P/OCF
for Maxigen Biotech Inc.

Provide P/FCFE
for Maxigen Biotech Inc.

Provide P/B
for Maxigen Biotech Inc.

Provide EV/S
for Maxigen Biotech Inc.

Provide EV/GP
for Maxigen Biotech Inc.

Provide EV/EBITDA
for Maxigen Biotech Inc.

Provide EV/EBIT
for Maxigen Biotech Inc.

Provide EV/OCF
for Maxigen Biotech Inc.

Provide EV/FCFF
for Maxigen Biotech Inc.

Provide EV/IC
for Maxigen Biotech Inc.

Show me price targets
for Maxigen Biotech Inc made by professional analysts.

What are the Revenue projections
for Maxigen Biotech Inc?

How accurate were the past Revenue estimates
for Maxigen Biotech Inc?

What are the Net Income projections
for Maxigen Biotech Inc?

How accurate were the past Net Income estimates
for Maxigen Biotech Inc?

What are the EPS projections
for Maxigen Biotech Inc?

How accurate were the past EPS estimates
for Maxigen Biotech Inc?

What are the EBIT projections
for Maxigen Biotech Inc?

How accurate were the past EBIT estimates
for Maxigen Biotech Inc?

Compare the revenue forecasts
for Maxigen Biotech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Maxigen Biotech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Maxigen Biotech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Maxigen Biotech Inc compared to its peers.

Compare the P/E ratios
of Maxigen Biotech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Maxigen Biotech Inc with its peers.

Analyze the financial leverage
of Maxigen Biotech Inc compared to its main competitors.

Show all profitability ratios
for Maxigen Biotech Inc.

Provide ROE
for Maxigen Biotech Inc.

Provide ROA
for Maxigen Biotech Inc.

Provide ROIC
for Maxigen Biotech Inc.

Provide ROCE
for Maxigen Biotech Inc.

Provide Gross Margin
for Maxigen Biotech Inc.

Provide Operating Margin
for Maxigen Biotech Inc.

Provide Net Margin
for Maxigen Biotech Inc.

Provide FCF Margin
for Maxigen Biotech Inc.

Show all solvency ratios
for Maxigen Biotech Inc.

Provide D/E Ratio
for Maxigen Biotech Inc.

Provide D/A Ratio
for Maxigen Biotech Inc.

Provide Interest Coverage Ratio
for Maxigen Biotech Inc.

Provide Altman Z-Score Ratio
for Maxigen Biotech Inc.

Provide Quick Ratio
for Maxigen Biotech Inc.

Provide Current Ratio
for Maxigen Biotech Inc.

Provide Cash Ratio
for Maxigen Biotech Inc.

What is the historical Revenue growth
over the last 5 years for Maxigen Biotech Inc?

What is the historical Net Income growth
over the last 5 years for Maxigen Biotech Inc?

What is the current Free Cash Flow
of Maxigen Biotech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Maxigen Biotech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Maxigen Biotech Inc

Current Assets 728.6m
Cash & Short-Term Investments 522.3m
Receivables 125.3m
Other Current Assets 81m
Non-Current Assets 838.6m
Long-Term Investments 396.1m
PP&E 433.3m
Intangibles 240k
Other Non-Current Assets 9m
Current Liabilities 235.6m
Accounts Payable 33.2m
Accrued Liabilities 60.1m
Other Current Liabilities 142.3m
Non-Current Liabilities 942k
Other Non-Current Liabilities 942k
Efficiency

Earnings Waterfall
Maxigen Biotech Inc

Revenue
609.2m TWD
Cost of Revenue
-194.1m TWD
Gross Profit
415.1m TWD
Operating Expenses
-290.2m TWD
Operating Income
124.9m TWD
Other Expenses
22.3m TWD
Net Income
147.2m TWD

Free Cash Flow Analysis
Maxigen Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Maxigen Biotech Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

62/100
Profitability
Score

Maxigen Biotech Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Maxigen Biotech Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
78/100
Solvency
Score

Maxigen Biotech Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Maxigen Biotech Inc

There are no price targets for Maxigen Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Maxigen Biotech Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Maxigen Biotech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Maxigen Biotech Inc Logo
Maxigen Biotech Inc

Country

Taiwan

Industry

Consumer products

Market Cap

3.7B TWD

Dividend Yield

0%

Description

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Contact

TAOYUAN
TAOYUAN
No.88, Keji 1st Road, Guishan District
+88633287222
mbi-bio.com

IPO

2011-05-18

Employees

-

Officers

GM & Representative Director
Ms. Ching-Ting Chen
Financial Officer & Accounting Officer
Ruei Yi Wu
Senior Manager of Administration
Ms. Karen Lee

See Also

Discover More
What is the Intrinsic Value of one Maxigen Biotech Inc stock?

The intrinsic value of one Maxigen Biotech Inc stock under the Base Case scenario is 28.59 TWD.

Is Maxigen Biotech Inc stock undervalued or overvalued?

Compared to the current market price of 42 TWD, Maxigen Biotech Inc is Overvalued by 32%.

Back to Top